Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet

Background: Colonic microbiome is thought to be involved in auto-immune multiple sclerosis (MS). Interactions between diet and the colonic microbiome in MS are unknown.Methods: We compared the composition of the colonic microbiota quantitatively in 25 MS patients and 14 healthy controls.Fluorescence...

Full description

Bibliographic Details
Main Authors: Alexander Swidsinski, Yvonne Dörffel, Vera Loening-Baucke, Christoph Gille, Önder Göktas, Anne Reißhauer, Jürgen Neuhaus, Karsten-Henrich Weylandt, Alexander Guschin, Markus Bock
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-06-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fmicb.2017.01141/full
_version_ 1818841555130122240
author Alexander Swidsinski
Alexander Swidsinski
Yvonne Dörffel
Vera Loening-Baucke
Christoph Gille
Önder Göktas
Anne Reißhauer
Jürgen Neuhaus
Karsten-Henrich Weylandt
Alexander Guschin
Markus Bock
author_facet Alexander Swidsinski
Alexander Swidsinski
Yvonne Dörffel
Vera Loening-Baucke
Christoph Gille
Önder Göktas
Anne Reißhauer
Jürgen Neuhaus
Karsten-Henrich Weylandt
Alexander Guschin
Markus Bock
author_sort Alexander Swidsinski
collection DOAJ
description Background: Colonic microbiome is thought to be involved in auto-immune multiple sclerosis (MS). Interactions between diet and the colonic microbiome in MS are unknown.Methods: We compared the composition of the colonic microbiota quantitatively in 25 MS patients and 14 healthy controls.Fluorescence in situ hybridization (FISH) with 162 ribosomal RNA derived bacterial FISH probes was used. Ten of the MS patients received a ketogenic diet for 6 months. Changes in concentrations of 35 numerically substantial bacterial groups were monitored at baseline and at 2, 12, and 23/24 weeks.Results: No MS typical microbiome pattern was apparent.The total concentrations and diversity of substantial bacterial groups were reduced in MS patients (P < 0.001). Bacterial groups detected with EREC (mainly Roseburia), Bac303 (Bacteroides), and Fprau (Faecalibacterium prausnitzii) probes were diminished the most. The individual changes were multidirectional and inconsistent. The effects of a ketogenic diet were biphasic. In the short term, bacterial concentrations and diversity were further reduced. They started to recover at week 12 and exceeded significantly the baseline values after 23–24 weeks on the ketogenic diet.Conclusions: Colonic biofermentative function is markedly impaired in MS patients.The ketogenic diet normalized concentrations of the colonic microbiome after 6 months.
first_indexed 2024-12-19T04:27:56Z
format Article
id doaj.art-38ecd4cc04f74be28d31eb1857d25a06
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-19T04:27:56Z
publishDate 2017-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-38ecd4cc04f74be28d31eb1857d25a062022-12-21T20:35:57ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2017-06-01810.3389/fmicb.2017.01141283641Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic DietAlexander Swidsinski0Alexander Swidsinski1Yvonne Dörffel2Vera Loening-Baucke3Christoph Gille4Önder Göktas5Anne Reißhauer6Jürgen Neuhaus7Karsten-Henrich Weylandt8Alexander Guschin9Markus Bock10Laboratory for Molecular Genetics, Polymicrobial Infections and Biofilms, Section of Gastroenterology and Hepatology, Department of Medicine, Charité Universitätsmedizin BerlinBerlin, GermanyInstitute of Molecular Medicine, Sechenov First Moscow State Medical UniversityMoscow, RussiaOutpatient Clinic, Charité Universitätsmedizin BerlinBerlin, GermanyLaboratory for Molecular Genetics, Polymicrobial Infections and Biofilms, Section of Gastroenterology and Hepatology, Department of Medicine, Charité Universitätsmedizin BerlinBerlin, GermanyLaboratory for Molecular Genetics, Polymicrobial Infections and Biofilms, Section of Gastroenterology and Hepatology, Department of Medicine, Charité Universitätsmedizin BerlinBerlin, GermanyLaboratory for Molecular Genetics, Polymicrobial Infections and Biofilms, Section of Gastroenterology and Hepatology, Department of Medicine, Charité Universitätsmedizin BerlinBerlin, GermanyLaboratory for Molecular Genetics, Polymicrobial Infections and Biofilms, Section of Gastroenterology and Hepatology, Department of Medicine, Charité Universitätsmedizin BerlinBerlin, GermanyFaculty of Veterinary Medicine, Centre for Infectious Diseases, University of LeipzigLeipzig, GermanyCharité Universitätsmedizin Berlin, Campus Virchow, Gastroenterology BerlinBerlin, GermanyLaboratory of Molecular Diagnostics, Russian Research Center for Molecular Diagnostics and Therapy, Central Research InstituteMoscow, RussiaExperimental and Clinical Research Center, A Joint Cooperation between the Charité Medical Faculty and the Max-Delbrueck Center for Molecular MedicineBerlin, GermanyBackground: Colonic microbiome is thought to be involved in auto-immune multiple sclerosis (MS). Interactions between diet and the colonic microbiome in MS are unknown.Methods: We compared the composition of the colonic microbiota quantitatively in 25 MS patients and 14 healthy controls.Fluorescence in situ hybridization (FISH) with 162 ribosomal RNA derived bacterial FISH probes was used. Ten of the MS patients received a ketogenic diet for 6 months. Changes in concentrations of 35 numerically substantial bacterial groups were monitored at baseline and at 2, 12, and 23/24 weeks.Results: No MS typical microbiome pattern was apparent.The total concentrations and diversity of substantial bacterial groups were reduced in MS patients (P < 0.001). Bacterial groups detected with EREC (mainly Roseburia), Bac303 (Bacteroides), and Fprau (Faecalibacterium prausnitzii) probes were diminished the most. The individual changes were multidirectional and inconsistent. The effects of a ketogenic diet were biphasic. In the short term, bacterial concentrations and diversity were further reduced. They started to recover at week 12 and exceeded significantly the baseline values after 23–24 weeks on the ketogenic diet.Conclusions: Colonic biofermentative function is markedly impaired in MS patients.The ketogenic diet normalized concentrations of the colonic microbiome after 6 months.http://journal.frontiersin.org/article/10.3389/fmicb.2017.01141/fullFISHcolonic microbiotamultiple sclerosisbiofermentationketogenic diet
spellingShingle Alexander Swidsinski
Alexander Swidsinski
Yvonne Dörffel
Vera Loening-Baucke
Christoph Gille
Önder Göktas
Anne Reißhauer
Jürgen Neuhaus
Karsten-Henrich Weylandt
Alexander Guschin
Markus Bock
Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet
Frontiers in Microbiology
FISH
colonic microbiota
multiple sclerosis
biofermentation
ketogenic diet
title Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet
title_full Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet
title_fullStr Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet
title_full_unstemmed Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet
title_short Reduced Mass and Diversity of the Colonic Microbiome in Patients with Multiple Sclerosis and Their Improvement with Ketogenic Diet
title_sort reduced mass and diversity of the colonic microbiome in patients with multiple sclerosis and their improvement with ketogenic diet
topic FISH
colonic microbiota
multiple sclerosis
biofermentation
ketogenic diet
url http://journal.frontiersin.org/article/10.3389/fmicb.2017.01141/full
work_keys_str_mv AT alexanderswidsinski reducedmassanddiversityofthecolonicmicrobiomeinpatientswithmultiplesclerosisandtheirimprovementwithketogenicdiet
AT alexanderswidsinski reducedmassanddiversityofthecolonicmicrobiomeinpatientswithmultiplesclerosisandtheirimprovementwithketogenicdiet
AT yvonnedorffel reducedmassanddiversityofthecolonicmicrobiomeinpatientswithmultiplesclerosisandtheirimprovementwithketogenicdiet
AT veraloeningbaucke reducedmassanddiversityofthecolonicmicrobiomeinpatientswithmultiplesclerosisandtheirimprovementwithketogenicdiet
AT christophgille reducedmassanddiversityofthecolonicmicrobiomeinpatientswithmultiplesclerosisandtheirimprovementwithketogenicdiet
AT ondergoktas reducedmassanddiversityofthecolonicmicrobiomeinpatientswithmultiplesclerosisandtheirimprovementwithketogenicdiet
AT annereißhauer reducedmassanddiversityofthecolonicmicrobiomeinpatientswithmultiplesclerosisandtheirimprovementwithketogenicdiet
AT jurgenneuhaus reducedmassanddiversityofthecolonicmicrobiomeinpatientswithmultiplesclerosisandtheirimprovementwithketogenicdiet
AT karstenhenrichweylandt reducedmassanddiversityofthecolonicmicrobiomeinpatientswithmultiplesclerosisandtheirimprovementwithketogenicdiet
AT alexanderguschin reducedmassanddiversityofthecolonicmicrobiomeinpatientswithmultiplesclerosisandtheirimprovementwithketogenicdiet
AT markusbock reducedmassanddiversityofthecolonicmicrobiomeinpatientswithmultiplesclerosisandtheirimprovementwithketogenicdiet